Table 4.
Liver-related adverse events at the end of observation.
PBC(N=226) | PBC/SS(N=56) | P value | |
---|---|---|---|
Death (%) | 9(4.0) | 2(3.6) | 0.877 |
HCC (%) | 2(0.8) | 1(1.8) | 0.557 |
Liver transplantation (%) | 2(0.8) | 0(0) | 0.481 |
Liver-related adverse events (%) | 13(5.8) | 3(5.4) | 1.000 |
HCC, hepatocellular carcinoma; SS, Sjögren's syndrome; and PBC, primary biliary cholangitis.